People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HeMemics Biotechnologies, Inc. | — | Biotechnology | Pre-Seed | $877K | $4.2M | 2018 |
James P. Hogarty at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James P. Hogarty on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Ho | 1 | 2 |
| Hoa Nguyen | 1 | 1 |
| Mary Schmidt | 1 | 1 |
| Hao Nguyen | 1 | 1 |
| John Warden | 1 | 1 |
| Dann Thomas | 1 | 1 |
| Maria Fattore | 1 | 1 |
| Larry P. Simpson | 1 | 1 |
| David H. Ho | 1 | 1 |
| Brandon B. Ho | 1 | 1 |
| Bruce A. Campbell | 1 | 1 |
| Roger S. Brook | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.